Fair Use This content is available for non-commercial reuse with proper attribution
Fermented foods containing probiotics may indirectly support GLP-1 production by promoting a healthy gut microbiome, though robust human evidence remains limited
Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis
Published in the New England Journal of Medicine in 2023, this phase 2 trial of retatrutide enrolled 338 adults with obesity
So, with a dose specifically tailored to the patient, the weight comes off
But what we are seeing is that GLP-1 coverage is getting more accessible for specific conditions sleep apnea, diabetes, extremely high BMI or a combination of these things but for other conditions, coverage is probably going to get more restrictive